Article: ALK-Abello's Grazax approved in Europe.(approval for Grazax the vaccine against grass pollen allergy )(Brief article)

Authorities in 27 European countries have now approved ALK-Abello's tablet-based vaccine against grass pollen allergy, Grazax - the first allergy tablet to address the underlying cause of the disease. The Denmark-based company expects to launch this on the first European markets by the end of 2006, ahead of the 2007 pollen season.

"We are very pleased to complete the European Mutual ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!